These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1138018)

  • 21. Osteoblast and osteoclast precursors in primary cultures of calvarial bone cells.
    Burger EH; Boonekamp PM; Nijweide PJ
    Anat Rec; 1986 Jan; 214(1):32-40. PubMed ID: 3954057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dichloromethylene diphosphonate (Cl2-MDP) on bone resorption induced by PHA-stimulated human mononuclear cells in organ culture.
    Holak HM; Szymaniec S; Skriabin A
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):77-83. PubMed ID: 6236769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes.
    Yoneda T; Mundy GR
    J Exp Med; 1979 Jan; 149(1):279-83. PubMed ID: 105076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes.
    Hersh EM; Harris JE
    J Immunol; 1968 Jun; 100(6):1184-94. PubMed ID: 5696282
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple roles of M-CSF in human osteoclastogenesis.
    Hodge JM; Kirkland MA; Nicholson GC
    J Cell Biochem; 2007 Oct; 102(3):759-68. PubMed ID: 17516513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood mononuclear cells develop into multinucleated osteoclasts in tissue culture.
    Shih C; Bernard GW
    Anat Rec; 1996 May; 245(1):41-5. PubMed ID: 8731038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines.
    Weksler ME; Birnbasum G
    J Clin Invest; 1972 Dec; 51(12):3124-32. PubMed ID: 4640952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transforming growth factor-beta on long-term human cord blood monocyte cultures.
    Orcel P; Bielakoff J; De Vernejoul MC
    J Cell Physiol; 1990 Feb; 142(2):293-8. PubMed ID: 1689319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement in irradiated mononuclear cells in culture of mitogen-induced incorporation of [3H]thymidine by homologous conditioned medium.
    Sandru G; Greiner R
    Radiat Res; 1994 Nov; 140(2):266-75. PubMed ID: 7938476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors.
    Zannettino AC; Farrugia AN; To LB; Atkins GJ
    Methods Mol Med; 2005; 113():245-56. PubMed ID: 15968108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of in vitro bone resorption: high-performance liquid chromatography measurement of the pyridinolines released in osteoclast cultures.
    Lorget F; Mentaverri R; Meddah B; Cayrolle G; Wattel A; Morel A; Schecroun N; Maamer M; de Vernejoul MC; Kamel S; Brazier M
    Anal Biochem; 2000 Sep; 284(2):375-81. PubMed ID: 10964422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of human/mouse hybridomas secreting a human lymphokine, osteoclast activating factor.
    Nedwin GE; Mohler MA; Luben RA
    Cell Immunol; 1984 Apr; 84(2):324-32. PubMed ID: 6368007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse.
    Horowitz M; Vignery A; Gershon RK; Baron R
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2181-5. PubMed ID: 6609360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy.
    Mundy GR; Rick ME; Turcotte R; Kowalski MA
    Am J Med; 1978 Oct; 65(4):600-6. PubMed ID: 707520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of osteoclast-activating factor (OAF) on the absorption of alveolar bone. II. Participation of the monocyte to OAF-producing cells].
    Marumoto Y; Fujihashi H; Sato I; Nakamura Y; Nishimoto M; Ikeda K
    Nihon Shishubyo Gakkai Kaishi; 1983 Dec; 25(4):823-9. PubMed ID: 6586890
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.
    Dewhirst FE; Stashenko PP; Mole JE; Tsurumachi T
    J Immunol; 1985 Oct; 135(4):2562-8. PubMed ID: 3875658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A factor in maternal plasma during pregnancy that suppresses the reactivity of mixed leukocyte cultures.
    Kasakura S
    J Immunol; 1971 Nov; 107(5):1296-301. PubMed ID: 5117669
    [No Abstract]   [Full Text] [Related]  

  • 38. [Osteoclast activating factor (OAF)].
    Kamihagi K; Katayama M; Kato I
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():756-8. PubMed ID: 8753352
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effects of osteoclast-activating factor (OAF) on the absorption of alveolar bone. 1. Production and purification of OAF (author's transl)].
    Marumoto Y; Kusunoki K; Fijihashi H; Osaka H; Nakamura Y; Ikeda K
    Nihon Shishubyo Gakkai Kaishi; 1982 Mar; 24(1):121-7. PubMed ID: 6980245
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic control of the response of chicken leucocytes to a T cell mitogen.
    Pink JR; Buder A; Miggiano VC
    Folia Biol (Praha); 1977; 23(6):417-8. PubMed ID: 608481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.